This site is intended for US healthcare professionals. For patient resources and support, click here indication

Style
Indication, hcp-banner

Actor portrayal of healthcare professionals reviewing medical imaging on monitors

Areas of focus

Style
no-header-background, transparent-header, no-vertical-section-spacing, hcp-image-banner

Our areas of focus

Discovering breakthrough therapies begins with understanding the diseases themselves. Learn more about Pfizer’s commitment to tackling some of the most challenging cancers.

Style
normal-section, header-section, section-container, areas-bg

Breast

A colored scanning electron micrograph showing breast cancer cells
A colored scanning electron micrograph showing breast cancer cells mobile

Breast cancer

Worldwide, breast cancer is the second-most common cancer in women, besides certain skin cancers. In fact, it’s estimated that breast cancer will be diagnosed in 12% of all US women over their lifetimes. The risk of death from breast cancer is going down—thanks to earlier detection, greater awareness, and advances in treatments.

Gastrointestinal

A 3D medical illustration of a malignant tumor growing on the lining of the human intestine A 3D medical illustration of a malignant tumor growing on the lining of the human intestine mobile

Colorectal cancer

Colorectal cancer (CRC), in patients whose cancer has spread, can have a poor prognosis, with a 5-year survival rate of under 20%. Breakthroughs in precision medicine and treatments are transforming care for patients with colorectal cancer, offering them more options.

Genitourinary

A colored scanning electron micrograph depicting two cancer cells in the process of dividing

A colored scanning electron micrograph depicting two cancer cells in the process of dividing mobile

Bladder cancer

Bladder cancer is the fourth most common cancer in men in the US. We are exploring the use of combination therapy in earlier stages of the disease while also testing additional medicines to expand future treatment options.

A color-enhanced scanning electron micrograph designed to represent the irregular, textured surface of cancer cells

A color-enhanced scanning electron micrograph designed to represent the irregular, textured surface of cancer cells mobile

Prostate cancer

Prostate cancer affects millions of men, with cases rising as the population ages. When prostate cancer spreads (in about 1 out of 5 cases), survival rates decline. Advances in treatments are creating new possibilities for patients with prostate cancer. Pfizer is providing research and development in this field.

Kidney cancer

Kidney cancer impacts thousands of people in the US every year, with half of the cases linked to lifestyle factors. Treatments like targeted therapies and immunotherapies are changing care for some patients.
Style
Column-2, accordion-equal-view, top-section-heading, area-of-focus-page-section, adjust-accordion, two-accordion

Hematological

A colored scanning electron micrograph that resembles blood cells from a patient with leukemia A colored scanning electron micrograph that resembles blood cells from a patient with leukemia mobile

Blood cancer

Annually, nearly 100,000 people in the US are diagnosed with blood cancers like multiple myeloma, leukemia, and lymphoma. Pfizer is committed to advancing research that may help patients facing these cancers.

Thoracic

A colored scanning electron micrograph (SEM) showing a cluster of lung cancer cells

A colored scanning electron micrograph (SEM) showing a cluster of lung cancer cells mobile

Lung cancer

Lung cancer remains the leading cause of cancer-related deaths among men and women, and it’s the second most common cancer in the US. Pfizer is studying potential treatments for certain types of non-small cell lung cancer (NSCLC).

Head & neck

About 4% of all cancers in the US are head and neck cancers. Despite an improved understanding of the molecular basis of these tumors, the identification of biomarkers, and the introduction of new treatments, outcomes have mostly remained unchanged for decades.
Style
Column-2, accordion-equal-view, area-of-focus-page-section, left-image, top-section-heading, adjust-accordion, custom-accordion

Other cancer types

A histopathology slide of a hypercellular tumor with a prominent vascular pattern

A histopathology slide of a hypercellular tumor with a prominent vascular pattern mobile

Additional tumor types

In addition to breast, colorectal, bladder, prostate, kidney, blood, lung, and head and neck cancers, other tumor types such as cervical and skin cancers are some of the most common cancers in the US. Pfizer continues to study ways to treat these cancers, offering potential hope for patients who need a new treatment option.

Cervical

For approximately 15% of patients with cervical cancer, their cancer has already spread at the time of diagnosis. Among women who are diagnosed with recurrent cervical cancer, the 5-year survival is under 5%. Recurrent or metastatic cervical cancer is a devastating and mostly incurable disease, with an urgent need for more treatment options.

Skin

Melanoma skin cancer is the fifth most common cancer in the US and causes the majority of skin cancer deaths.
Style
Column-2, accordion-equal-view, top-section-heading, area-of-focus-page-section, other-type-section, left-image, adjust-accordion, custom-accordion